The Centers for Disease Control and Prevention recommends a 2026-2027 COVID-19 vaccine for all adults 18 and older and for all children 6 months through 17 years who are moderately or severely immunocompromised. For all other children in that age range, the CDC recommends a COVID-19 vaccine through shared clinical decision-making, a decision made between a health care provider and the patient or parent. This page reports what the CDC and the FDA state and is not medical advice.
The CDC recommendation, group by group
As listed in the CDC's clinical considerations and immunocompromised guidance, both updated September 23, 2026, and its vaccine benefits page, updated October 8, 2026:
| Group | What the CDC recommends |
|---|---|
| Adults 18 to 64 | A 2026-2027 vaccine |
| Adults 65 and older | A 2026-2027 vaccine, and a second dose 6 months after the first |
| Moderately or severely immunocompromised, 6 months and older | 2 doses of 2026-2027 vaccine spaced 6 months apart for those who completed an initial series; 3 or 4 doses for those never vaccinated |
| Children 6 months through 17 years, not immunocompromised | Shared clinical decision-making |
The CDC's benefits page gives the reason for the second dose: adults 65 and older and people with a weakened immune system have a higher risk for severe COVID-19. The same page says a COVID-19 vaccine during pregnancy helps protect the mother and helps protect the baby before the baby becomes eligible for vaccination at 6 months old.
The CDC's clinical considerations add that all patients should discuss the benefits and risks of COVID-19 vaccination with their health care providers to make informed and personalized decisions.
What shared clinical decision-making means for children
The CDC's child schedule notes say these vaccinations are individually based and informed by a decision process between the provider and the patient or parent or guardian. Where a parent wants a child vaccinated, the notes say children 6 months and older may receive a COVID-19 vaccine, informed by the provider's clinical judgment and personal preference and circumstances. The same notes list 18-year-olds who are not moderately or severely immunocompromised under routine vaccination.